Pharma Manufacturing

Menu

Newsletters
Subscribe

Newsletters
Subscribe

Follow us on:

Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sector

Home|
Solution Providers|
E-News|
Subscribe|
Resource Directory|
Webinars|
Current Issue

Follow us on:

Home / Industry News / 2012 / Anti-counterfeit Market on Path to Strong Growth

Anti-counterfeit Market on Path to Strong Growth

Source: PharmaManufacturing.com

Oct 31, 2012

SecuringIndustry.com

Show More Content

More News:

Pfizer recalls migraine drug for possible microbial contamination

08/16/2019

Pfizer has recalled two lots of migraine drug Relpax after finding those lots “may not meet Pfizer’s in-house microbiological specification for the potential presence” of two kinds of bacteria.
Sanofi wins appeal for Jevtana patent

08/15/2019

A federal appeals court affirmed the validity of Sanofi's first patent on prostate-cancer drug, Jevtana.
Pharma in review: trending stories 8/16/19

08/15/2019

Most popular Pharma Manufacturing stories from the past seven days.
Top Novartis scientists exited company ahead of data scandal

08/14/2019

More details are emerging about the months leading up to Novartis’s admission that data results for its gene therapy Zolgensma were manipulated.
Ovarian cancer drug hits main goal in new study

08/14/2019

An AstraZeneca treatment scored an important victory in the quest to offer new treatments for ovarian cancer.
Eli Lilly psoriasis drug bests J&J rival

08/13/2019

The drugmaker's Taltz beat out Johnson & Johnson's Tremfya at achieving total skin clearance after 12 weeks of treatment
FDA expands Regeneron's Eylea approval

08/13/2019

The blockbuster eye med is now indicated for an Injection prefilled syringe, which will provide physicians with a new way to administer the treatment with fewer preparation steps
Regeneron drug boosts survival of Ebola to 90 percent

08/12/2019

A new study has shown that a pair of experimental treatments could dramatically increase the chances of surviving Ebola.
Amgen wins Enbrel patent protections — for now

08/12/2019

Amgen has fought off a patent challenge from Novartis to its blockbuster anti-inflammatory, Enbrel.
GSK announces leadership changes

08/12/2019

GlaxoSmithKline announced that Jack Bailey, President U.S. Pharmaceuticals, has decided to step down from his role at the end of the year.

All news

Most Popular

Past 7 Days
Past 30 Days
Past 6 Months

01

Top Novartis scientists exited company ahead of data scandal

More details are emerging about the months leading up to Novartis’s…
02

2019 Pharma Innovation Awards

This year's winners offer slices of innovation
03

Qualifying your cleanroom

Revised GMP guidelines will strengthen emphasis on contamination control,…
04

Regeneron drug boosts survival of Ebola to 90 percent

A new study has shown that a pair of experimental treatments could…
05

Pfizer recalls migraine drug for possible microbial contamination

Pfizer has recalled two lots of migraine drug Relpax after finding those…

01

FDA says Novartis gene therapy drug application contains manipulated data

On May 24, the FDA approved Zolgensma, a gene therapy product intended to…
02

What’s behind all the M&A deals in pharma?

As far as M&A deals go, 2019 has started off with a boom.
03

10 of the highest-paid CEOs in pharma
04

Celgene snags new approval for Otezla

Celgene announced that the U.S. FDA has approved Otezla for the treatment…
05

Top Novartis scientists exited company ahead of data scandal

More details are emerging about the months leading up to Novartis’s…

01

Merck to cut jobs, close plants with $1.2B restructuring plan

Merck and Co. has created a restructuring plan it says is designed to…
02

The Highest — and Lowest — Ranked Places to Work in Big Pharma

How pharma companies fair on Glassdoor.
03

Torrent hit with Form 483

The FDA found that in hundreds of cases, batches at Torrent’s plant did…
04

Anti-vaxxers turn to potatoes

A new and weird rumor has surfaced in the anti-vaccine movement: potatoes…
05

FDA says Novartis gene therapy drug application contains manipulated data

On May 24, the FDA approved Zolgensma, a gene therapy product intended to…

Pharma Manufacturing

About

General Information
Contact Us
Subscription Services
Media Kit
Editorial Calendar
Editorial Submissions Guidelines
Editorial Advisory Board

Content

Resource Libraries
OpEd
Fundamentals
News
Articles
White Papers
Products
All Star Innovators
Funny Pharm

Magazine

Subscribe (print)
Current Issue
Issue Archive

Site Tools

Site Map
Resource Directory

Stay Connected

My Account
Events Calendar
E-Newsletters
Human Interest
Facebook
Twitter
LinkedIn
YouTube
RSS Feed

Contact Us | Advertise | Privacy Policy | Legal Disclaimers, Terms & Conditions

Copyright © 2004 - 2019 Pharma Manufacturing. All rights reserved.

P: 630-467-1300 | 1501 E. Woodfield Road, Suite 400N, Schaumburg, IL 60173

Chemical Processing | Control | Control Design | Food Processing | Pharma Manufacturing | Plant Services | Smart Industry